looking at selling $600-$800m of assets over next 12 months and totally eliminating the loan assets - gearing will be reduced to 55-65%...this is good right?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%